GST is an R&D and production company for veterinary stem cell products. As a basis for these stem cell therapies, GST uses highly potent stem cells from blood of mammals.
| Website | http://www.gst.be |
| Revenue | $6 million |
| Employees | View employees |
| Address | 4 Noorwegenstraat, Evergem, Flanders 9940, BE |
| Phone | +32 9 257 15 00 |
| Fax | (329) 257-1538 |
| Industry | Business Services General, Business Services |
| Competitors | Mesoblast Limited, Athersys, Cynata Therapeutics, Tissue Regenix Group, Regenexx Physicians, Celularity Inc., Organogenesis, STEMCELL Technologies, Gamida Cell Ltd., Kymab Ltd +48 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Global Stem Cell Technology employee's phone or email?
Global Stem Cell Technology Questions
The Global Stem Cell Technology annual revenue was $6 million in 2026.
Global Stem Cell Technology is based in Evergem, Flanders.
The NAICS codes for Global Stem Cell Technology are [5417, 541713, 54, 541, 54171].
The SIC codes for Global Stem Cell Technology are [873, 87].
G2Crowd Trusted
300K+
Plugin Users
